{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:49Z","timestamp":1773287089376,"version":"3.50.1"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Q fever is a zoonotic disease caused by infection with the bacterium\n            <jats:named-content content-type=\"genus-species\">Coxiella burnetii<\/jats:named-content>\n            . Infection with\n            <jats:named-content content-type=\"genus-species\">C. burnetii<\/jats:named-content>\n            results in humoral and cellular immune responses, both of which are thought to contribute to protection against subsequent infection. Whole-cell formalin-inactivated vaccines have also been shown to induce both humoral and cellular immunity and provide protection. Whether measurement of cellular or humoral immunity is a better indicator of immune protection is not known, and the duration of immunity induced by natural infection or vaccination is also poorly understood. To better understand the measurement and duration of\n            <jats:named-content content-type=\"genus-species\">C. burnetii<\/jats:named-content>\n            immunity, 16 people vaccinated against Q fever (0.2 to 10.3 years before analysis) and 29 controls with a low risk of Q fever exposure were tested for immune responses to\n            <jats:named-content content-type=\"genus-species\">C. burnetii<\/jats:named-content>\n            by an indirect fluorescent-antibody test (IFA) to measure circulating antibody and by a gamma interferon release assay (IGRA) to measure cellular immunity. Among vaccinated subjects, the IFA detected antibodies in 13\/16, and the IGRA also detected positive responses in 13\/16. All of the vaccinated subjects had a positive response in at least one of the assays, whereas 8\/29 control subjects were positive in at least one assay. There was not a correlation between time since vaccination and responses in these assays. These results show that IFA and IGRA perform similarly in detection of\n            <jats:named-content content-type=\"genus-species\">C. burnetii<\/jats:named-content>\n            immune responses and that Q fever vaccination establishes long-lived immune responses to\n            <jats:named-content content-type=\"genus-species\">C. burnetii<\/jats:named-content>\n            .\n          <\/jats:p>","DOI":"10.1128\/cvi.00613-12","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T01:23:43Z","timestamp":1354238623000},"page":"129-133","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":33,"title":["Long-Term Immune Responses to Coxiella burnetii after Vaccination"],"prefix":"10.1128","volume":"20","author":[{"given":"Gilbert J.","family":"Kersh","sequence":"first","affiliation":[{"name":"Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua S.","family":"Self","sequence":"additional","affiliation":[{"name":"Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[{"name":"Office of the Director, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Massung","sequence":"additional","affiliation":[{"name":"Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.518"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3201\/eid1703.100882","article-title":"Q fever in France, 1985\u20132009","volume":"17","author":"Frankel D","year":"2011","unstructured":"FrankelD RichetH RenvoiseA RaoultD. 2011. Q fever in France, 1985\u20132009. Emerg. Infect. Dis. 17:350\u2013356.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/15303660260613747","article-title":"Q fever in humans and animals in the United States","volume":"2","author":"McQuiston JH","year":"2002","unstructured":"McQuistonJH ChildsJE. 2002. Q fever in humans and animals in the United States. Vector Borne Zoonotic Dis. 2:179\u2013191.","journal-title":"Vector Borne Zoonotic Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12026-008-8059-4","article-title":"Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii","volume":"43","author":"Shannon JG","year":"2009","unstructured":"ShannonJG HeinzenRA. 2009. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol. Res. 43:138\u2013148.","journal-title":"Immunol. Res."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00454-09"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/qjmed\/hcq113","article-title":"Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens","volume":"103","author":"Sukocheva OA","year":"2010","unstructured":"SukochevaOA MarmionBP StormPA LockhartM TurraM GravesS. 2010. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens. Q. J. Med. 103:847\u2013863.","journal-title":"Q. J. Med."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/qjmed\/hcs119","article-title":"An analysis of Q fever patients 6 years after an outbreak in Newport, Wales, UK","volume":"105","author":"Hussain-Yusuf H","year":"2012","unstructured":"Hussain-YusufH IslamA HealyB LockhartM NguyenC SukochevaO StenosJ GravesS. 2012. An analysis of Q fever patients 6 years after an outbreak in Newport, Wales, UK. Q. J. Med. 105:1067\u20131073.","journal-title":"Q. J. Med."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.11.2.280-286.1975"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00101-10"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice","volume":"179","author":"Zhang G","year":"2007","unstructured":"ZhangG Russell-LodrigueKE AndohM ZhangY HendrixLR SamuelJE. 2007. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice. J. Immunol. 179:8372\u20138380.","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs","volume":"104","author":"Marmion BP","year":"1990","unstructured":"MarmionBP OrmsbeeRA KyrkouM WrightJ WorswickDA IzzoAA EstermanA FeeryB ShapiroRA. 1990. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol. Infect. 104:275\u2013287.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_13_2","volume-title":"Protecting the frontline in biodefense research: the Special Immunizations Program","author":"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents","year":"2011","unstructured":"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents. 2011. Protecting the frontline in biodefense research: the Special Immunizations Program. The National Academies Press, Washington, DC."},{"key":"e_1_3_2_14_2","article-title":"Time-course of antibody responses against Coxiella burnetii following acute Q fever","author":"Teunis PF","year":"2012","unstructured":"TeunisPF SchimmerB NotermansDW LeendersAC WeverPC KretzschmarME SchneebergerPM. 4 April 2012. Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol. Infect. doi:10.1017\/S09502688120004040.","journal-title":"Epidemiol. Infect"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2249.1993.tb08226.x","article-title":"Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects","volume":"94","author":"Izzo AA","year":"1993","unstructured":"IzzoAA MarmionBP. 1993. Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects. Clin. Exp. Immunol. 94:507\u2013515.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.35.3.1091-1102.1982"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb19633.x","article-title":"Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetii for the immunization of animals","volume":"653","author":"Williams JC","year":"1992","unstructured":"WilliamsJC PeacockMG WaagDM KentG EnglandMJ NelsonG StephensonEH. 1992. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetii for the immunization of animals. Ann. N. Y. Acad. Sci. 653:88\u2013111.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S0950268811000021","article-title":"The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population","volume":"140","author":"Blaauw GJ","year":"2012","unstructured":"BlaauwGJ NotermansDW SchimmerB MeekelenkampJ ReimerinkJH TeunisP SchneebergerPM. 2012. The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population. Epidemiol. Infect. 140:36\u201341.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_19_2","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek GH","year":"2010","unstructured":"MazurekGH JerebJ VernonA LoBueP GoldbergS CastroK. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recommend. Rep. 59:1\u201325.","journal-title":"MMWR Recommend. Rep."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","article-title":"Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection","volume":"286","author":"Mazurek GH","year":"2001","unstructured":"MazurekGH LoBuePA DaleyCL BernardoJ LardizabalAA BishaiWR IademarcoMF RothelJS. 2001. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286:1740\u20131747.","journal-title":"JAMA"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1574-695X.2011.00890.x","article-title":"Developing a new clinical tool for diagnosing chronic Q fever: the Coxiella ELISPOT","volume":"64","author":"Limonard GJ","year":"2012","unstructured":"LimonardGJ ThijsenSF BossinkAW AsschemanA BouwmanJJ. 2012. Developing a new clinical tool for diagnosing chronic Q fever: the Coxiella ELISPOT. FEMS Immunol. Med. Microbiol. 64:57\u201360.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.2009.09-0168","article-title":"Seroprevalence of Q fever in the United States, 2003\u20132004","volume":"81","author":"Anderson AD","year":"2009","unstructured":"AndersonAD Kruszon-MoranD LoftisAD McQuillanG NicholsonWL PriestleyRA CandeeAJ PattersonNE MassungRF. 2009. Seroprevalence of Q fever in the United States, 2003\u20132004. Am. J. Trop. Med. Hyg. 81:691\u2013694.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/653675"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1071\/NB07057","article-title":"A review of the efficacy of human Q fever vaccine registered in Australia","volume":"18","author":"Chiu CK","year":"2007","unstructured":"ChiuCK DurrheimDN. 2007. A review of the efficacy of human Q fever vaccine registered in Australia. N. S. W. Public Health Bull. 18:133\u2013136.","journal-title":"N. S. W. Public Health Bull."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00613-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00613-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:48:34Z","timestamp":1627591714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00613-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1128\/CVI.00613-12"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00613-12","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"2012-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}